Postoperative analgesic effect of intrathecal morphine in total ankle replacement arthroplasty

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0002248

Enrollment

Registered

2017-02-28

Start date

2017-01-31

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : This study is randomized controlled trial, all patients undergoing total ankle replacement surgury were randomized to one of the four gruops by dose. All patients receive spinal anesthesia by u

heavy bupivacaine HCL with the assigned intrathecal morpine sulfate dose(0mg/0.1mg/0.2mg/0.3mg).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who performed a total ankle replacement surgery under spinal anesthesia( 20~ 75 years) American Society of Anesthesiologist physical status I,II,III

Exclusion criteria

Exclusion criteria: Patients who refused spinal anesthesia Pateints who used opioids over a long period of time(30 mg/d of oral morphine or the equivalent) or had a serious side effect of opioid. Patients who have significant coagulopathy or generalized infection Patients who is unable to voluntarily agree to participate in the research

Design outcomes

Primary

Measure	Time frame
total IV morphine use for the first 24 h after surgery	—

Secondary

Measure	Time frame
VAS(visual analog scales) pain score after surgery;duration of analgesia;the incidence of complications	—

Countries

Korea, Republic of

Contacts

Public Contacthuigyeong Park

Samsung Medical Center

click1201@naver.com+82-2-3410-2470

Outcome results